Correspondingly, silencing SIRT6 suppressed the downstream molecules of mTOR pathway in both prostate cancer cell lines and in vivo tissue samples (Figure 5L, S5F, S5G). This evidence concerns the gene SIRT6 and prostate carcinoma.